Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 256

1.

Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury.

Sommer J, Dorn C, Gäbele E, Bataille F, Freese K, Seitz T, Thasler WE, Büttner R, Weiskirchen R, Bosserhoff A, Hellerbrand C.

Cells. 2020 Jan 19;9(1). pii: E248. doi: 10.3390/cells9010248.

2.

Dysregulated mesenchymal PDGFR-β drives kidney fibrosis.

Buhl EM, Djudjaj S, Klinkhammer BM, Ermert K, Puelles VG, Lindenmeyer MT, Cohen CD, He C, Borkham-Kamphorst E, Weiskirchen R, Denecke B, Trairatphisan P, Saez-Rodriguez J, Huber TB, Olson LE, Floege J, Boor P.

EMBO Mol Med. 2020 Jan 14:e11021. doi: 10.15252/emmm.201911021. [Epub ahead of print]

3.

All You Can Feed: Some Comments on Production of Mouse Diets Used in Biomedical Research with Special Emphasis on Non-Alcoholic Fatty Liver Disease Research.

Weiskirchen S, Weiper K, Tolba RH, Weiskirchen R.

Nutrients. 2020 Jan 7;12(1). pii: E163. doi: 10.3390/nu12010163. Review.

4.

Identification of Pparγ-modulated miRNA hubs that target the fibrotic tumor microenvironment.

Winkler I, Bitter C, Winkler S, Weichenhan D, Thavamani A, Hengstler JG, Borkham-Kamphorst E, Kohlbacher O, Plass C, Geffers R, Weiskirchen R, Nordheim A.

Proc Natl Acad Sci U S A. 2020 Jan 7;117(1):454-463. doi: 10.1073/pnas.1909145117. Epub 2019 Dec 23.

5.

Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases.

van der Heide D, Weiskirchen R, Bansal R.

Front Immunol. 2019 Dec 3;10:2852. doi: 10.3389/fimmu.2019.02852. eCollection 2019. Review.

6.

Elevated MR-proANP plasma concentrations are associated with sepsis and predict mortality in critically ill patients.

Yagmur E, Sckaer JH, Koek GH, Weiskirchen R, Trautwein C, Koch A, Tacke F.

J Transl Med. 2019 Dec 12;17(1):415. doi: 10.1186/s12967-019-02165-2.

7.

Mast Cells in Liver Fibrogenesis.

Weiskirchen R, Meurer SK, Liedtke C, Huber M.

Cells. 2019 Nov 13;8(11). pii: E1429. doi: 10.3390/cells8111429. Review.

8.

Investigation of soluble anti-Müllerian hormone receptor type 2 as a biomarker for diagnosis of female fertility disorders.

Olivier LS, Evliyaoglu O, Weiskirchen R, van Helden J.

Reprod Biomed Online. 2019 Dec;39(6):1017-1025. doi: 10.1016/j.rbmo.2019.08.007. Epub 2019 Aug 27.

PMID:
31727499
9.
10.

Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury.

Weiskirchen R.

Front Pharmacol. 2019 Oct 25;10:1289. doi: 10.3389/fphar.2019.01289. eCollection 2019. No abstract available.

11.

Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview.

Pinheiro D, Dias I, Ribeiro Silva K, Stumbo AC, Thole A, Cortez E, de Carvalho L, Weiskirchen R, Carvalho S.

Cells. 2019 Oct 29;8(11). pii: E1339. doi: 10.3390/cells8111339. Review.

12.

Magnetic-Assisted Treatment of Liver Fibrosis.

Levada K, Omelyanchik A, Rodionova V, Weiskirchen R, Bartneck M.

Cells. 2019 Oct 19;8(10). pii: E1279. doi: 10.3390/cells8101279. Review.

13.

Reference change values of M-protein, free light chain and immunoglobulins in monoclonal gammopathy.

Evliyaoglu O, van Helden J, Jaruschewski S, Imöhl M, Weiskirchen R.

Clin Biochem. 2019 Dec;74:42-46. doi: 10.1016/j.clinbiochem.2019.09.004. Epub 2019 Sep 14.

PMID:
31526775
14.

Endoglin Trafficking/Exosomal Targeting in Liver Cells Depends on N-Glycosylation.

Meurer S, Wimmer AE, Leur EV, Weiskirchen R.

Cells. 2019 Aug 28;8(9). pii: E997. doi: 10.3390/cells8090997.

15.

High Prevalence of Sticky Platelet Syndrome in Patients with Infertility and Pregnancy Loss.

Yagmur E, Bast E, Mühlfeld AS, Koch A, Weiskirchen R, Tacke F, Neulen J.

J Clin Med. 2019 Aug 28;8(9). pii: E1328. doi: 10.3390/jcm8091328.

16.

Phosphatidylcholine Passes by Paracellular Transport to the Apical Side of the Polarized Biliary Tumor Cell Line Mz-ChA-1.

Stremmel W, Staffer S, Weiskirchen R.

Int J Mol Sci. 2019 Aug 19;20(16). pii: E4034. doi: 10.3390/ijms20164034.

17.

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH).

Drescher HK, Weiskirchen S, Weiskirchen R.

Cells. 2019 Aug 7;8(8). pii: E845. doi: 10.3390/cells8080845. Review.

18.

The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH).

Drescher HK, Weiskirchen R, Fülöp A, Hopf C, de San Román EG, Huesgen PF, de Bruin A, Bongiovanni L, Christ A, Tolba R, Trautwein C, Kroy DC.

Front Physiol. 2019 Jun 25;10:770. doi: 10.3389/fphys.2019.00770. eCollection 2019.

19.

Decreased CTRP3 Plasma Concentrations Are Associated with Sepsis and Predict Mortality in Critically Ill Patients.

Yagmur E, Otto S, Koek GH, Weiskirchen R, Trautwein C, Koch A, Tacke F.

Diagnostics (Basel). 2019 Jun 21;9(2). pii: E63. doi: 10.3390/diagnostics9020063.

20.

The interesting case-orphan diseases-double trouble.

Reuner U, Stremmel W, Weiskirchen R.

Ann Transl Med. 2019 Apr;7(Suppl 2):S74. doi: 10.21037/atm.2019.04.31.

Supplemental Content

Loading ...
Support Center